Target intelligence / Profile preview

HIG1 hypoxia inducible domain family member 1A pseudogene 8 (HIGD1AP8)

Target: HIGD1AP8
Molecular classification: Other (Processed pseudogene)

Overview

HIGD1AP8, or HIG1 hypoxia inducible domain family member 1A pseudogene 8, is classified as a processed pseudogene in the human genome, identified by sources such as NCBI Gene (ID: 100874451), HGNC (Symbol: HIGD1AP8, Accession: HGNC:43003), and Ensembl (ENSG00000237303)[1][3][5][6]. Processed pseudogenes are nonfunctional copies of protein-coding genes that arise via reverse transcription and reintegration into the genome, lacking the potential to encode proteins[4]. HIGD1AP8 is a retrocopy of the functional HIGD1A gene, but there is no established evidence that it encodes a protein or acts directly as a functional therapeutic target[7][8][3][5]. While pseudogenes as a class can sometimes regulate the expression of their parent genes or other genes through RNA-based mechanisms, no specific function or disease association has been reported for HIGD1AP8 to date[4][6].

Other names: HIGD1AP8HIG1 hypoxia inducible domain family member 1A pseudogene 8

Mechanism of action

None

Biological functions

None established specifically for HIGD1AP8; as a general class, some processed pseudogenes may have regulatory roles at the RNA level, but this has not been demonstrated for HIGD1AP8

Disease associations

None specifically, but pseudogenes may play regulatory roles in cancer and other diseases through RNA-mediated mechanisms

Beyond the preview

Go deeper on HIG1 hypoxia inducible domain family member 1A pseudogene 8 (HIGD1AP8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIG1 hypoxia inducible domain family member 1A pseudogene 8 (HIGD1AP8).

Explore the full profile